Torticollis

(redirected from Spasmodic torticollis)
Also found in: Dictionary, Thesaurus, Medical, Acronyms, Wikipedia.

torticollis

[‚tȯrd·ə′käl·əs]
(medicine)
A deformity of the neck resulting from contraction of the cervical muscles or fascia. Also known as wryneck.

Torticollis

 

or wryneck, a deformity of the neck caused by a unilateral tension of the muscles and soft tissues of the neck, or by distortion of the neck region of the spine; it is accompanied by improper position of the head. Congenital torticollis is a result of improper intrauterine development or birth trauma; acquired torticollis appears after injury or burns or as a result of inflammation of the muscles or lymph glands of the neck.

The head is inclined to the side of the affected muscle, the occiput approaches the shoulder on that side, and the chin is turned and raised toward the opposite side. Head movements, especially lateral ones, are substantially limited. If there has been no timely treatment, such secondary deformities as asymmetry of the face and skull and deformation of the spine are added to the basic deformity. Torticollis is treated by an orthopedic physician.

REFERENCES

Zatsepin, S. T. Ortopediia detskogo i podrostkovogo vozrasta, 2nd ed. Moscow, 1956.
Zatsepin, S. T. Vrozhdennaia myshechnaia krivosheia. Moscow, 1960. (Bibliography.)
References in periodicals archive ?
Treatment of spasmodic torticollis with local injections of botulinum toxin.
net/users/dystonia/ The National Spasmodic Torticollis Association in Wisconsin can be reached at (800) 487-8385.
I, too, have suffered from Spasmodic Torticollis, so I know of the pain she is in.
She developed spasmodic torticollis - a brain disorder which sends bogus messages to the neck muscles and pulls her head down to one side.
According to the Dystonia Medical Research Foundation, approximately 300,000 people in North America suffer from some form of dystonia, which ranges from writer's cramp to spasmodic torticollis.
Mentor Corporation (NYSE:MNT), a leading supplier of medical products in the United States and internationally, today announced that it has initiated the Phase 1 study of its proprietary botulinum toxin type A product, focused on the therapeutic indication of the treatment of pain associated with adult onset spasmodic torticollis in the United States.